Ocular Therapeutix Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 32.65 M | $276.58 M | 2.73% | 17.44% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 19.69 M | $166.74 M | 143.93% | 10.51% |
| BLACKROCK, INC. | 05/13/2026 | 16.13 M | $136.65 M | 3.40% | 8.62% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2026 | 12.32 M | $104.31 M | 14.26% | 6.58% |
| SUMMER ROAD LLC | 04/23/2026 | 11.88 M | $100.62 M | 6.94% | 6.34% |
| VR ADVISER, LLC | 05/15/2026 | 10.35 M | $87.64 M | 41.44% | 5.53% |
| 05/15/2026 | 8.72 M | $73.85 M | 100.00% | 4.66% | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 5.90 M | $49.95 M | 3,338.09% | 3.15% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 5.53 M | $46.88 M | 444.65% | 2.96% |
| STATE STREET CORP | 05/15/2026 | 4.71 M | $39.88 M | 12.20% | 2.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 4.53 M | $38.37 M | 3.96% | 2.42% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 4.13 M | $50.13 M | -4.89% | 2.21% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 3.85 M | $32.61 M | 10.00% | 2.06% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 3.17 M | $26.82 M | 20.70% | 1.69% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 2.69 M | $22.81 M | 252.64% | 1.44% |
| COMMODORE CAPITAL LP | 05/15/2026 | 2.58 M | $21.81 M | 100.00% | 1.38% |
| DELTEC ASSET MANAGEMENT LLC | 04/24/2026 | 2.34 M | $19.83 M | -5.92% | 1.25% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.83 M | $15.50 M | 380.72% | 0.98% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.67 M | $14.12 M | 0.09% | 0.89% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 1.65 M | $13.96 M | -71.29% | 0.88% |
| 05/08/2026 | 1.59 M | $13.51 M | 100.00% | 0.85% | |
| INVESCO LTD. | 05/12/2026 | 1.54 M | $13.02 M | 71.58% | 0.82% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.53 M | $12.92 M | 4.32% | 0.81% |
| UBS GROUP AG | 05/05/2026 | 1.52 M | $12.88 M | 22.14% | 0.81% |
| 06/12/2026 | 1.49 M | $12.60 M | 118.24% | 0.79% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.46 M | $12.38 M | 0.05% | 0.78% |
| MORGAN STANLEY | 05/15/2026 | 1.28 M | $10.84 M | 45.61% | 0.68% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 1.25 M | $10.55 M | 100.00% | 0.66% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 1.18 M | $9.96 M | 5,778.50% | 0.63% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 1.15 M | $9.72 M | 45.09% | 0.61% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.11 M | $9.40 M | -28.25% | 0.59% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 980.76 K | $8.31 M | 122.68% | 0.52% |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 968.60 K | $8.20 M | 100.00% | 0.52% |
| CANDRIAM S.C.A. | 04/30/2026 | 949.22 K | $8.04 M | 12.79% | 0.51% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/13/2026 | 902.93 K | $7.65 M | -15.09% | 0.48% |
| EMPIRE LIFE INVESTMENTS INC. | 05/11/2026 | 884.30 K | $7.37 M | 63.72% | 0.47% |
| READYSTATE ASSET MANAGEMENT LP | 05/15/2026 | 883.62 K | $7.48 M | 100.00% | 0.47% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 859.49 K | $7.28 M | 2.05% | 0.46% |
| JANE STREET GROUP, LLC | 05/12/2026 | 804.59 K | $6.81 M | -22.20% | 0.43% |
| CETERA INVESTMENT ADVISERS | 05/13/2026 | 764.62 K | $6.48 M | 5.82% | 0.41% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 741.14 K | $6.28 M | 221.52% | 0.40% |
| MARSHALL WACE, LLP | 05/15/2026 | 740.80 K | $6.27 M | -46.21% | 0.40% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 04/23/2026 | 720.46 K | $6.10 M | 26.15% | 0.38% |
| HRT FINANCIAL LP | 05/14/2026 | 709.22 K | $6.01 M | 76.00% | 0.38% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 649.76 K | $5.49 M | 100.00% | 0.35% |
| CITADEL ADVISORS LLC | 05/15/2026 | 635.92 K | $5.39 M | -74.32% | 0.34% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 631.74 K | $5.35 M | 6.94% | 0.34% |
| TUDOR INVESTMENT CORP ET AL | 05/15/2026 | 614.38 K | $5.20 M | 24.17% | 0.33% |
| KNOLL CAPITAL MANAGEMENT, LLC | 05/15/2026 | 600.40 K | $5.09 M | 0.00% | 0.32% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 600.00 K | $5.08 M | -62.38% | 0.32% |
Ocular Therapeutix Inc institutional Ownership - FAQ's
During the previous two years, 345 institutional investors and hedge funds held shares of Ocular Therapeutix Inc. The most heavily invested institutionals were:
FMR LLC: 32.65 M
Deep Track Capital, LP: 19.69 M
BlackRock, Inc.: 16.13 M
Avoro Capital Advisors LLC: 12.32 M
SUMMER ROAD LLC: 11.88 M
VR Adviser, LLC: 10.35 M
110.41% of Ocular Therapeutix Inc stock is owned by institutional investors.
Institutional investors have bought a total of 221.77 M shares in the last 24 months. This purchase volume represents approximately $2.20 B in transactions.